Skip to main content

The court’s judgment on the true identity of the author responsible for identity fraud and the consequent batch retraction of Iranian’s papers in the journal of diagnostic pathology

Abstract

This letter concerns retracted papers published in the Journal of Diagnostic Pathology, where my name was misused as the author or corresponding author without my permission or knowledge. Considering that all misconducts were directed by an author during initial manuscripts’ submissions, I opened a case in Iran’s Cyber Police (FATA) to unravel the true identity of the submitting author. After Cyber Police’s report revealed the true identity of the submitting author, the court started a thorough investigation and finally convicted the submitting author for identity fraud and data forgery through creating and using fake email addresses.

This clarification letter concerns the batch retraction of Iranian’s papers published in the Journal of Diagnostic Pathology [1,2,3,4,5] in November 2016, particularly in which my name was misused as the author or corresponding author. However, in the published reports, authorship and peer-review manipulations had been stated as the main reasons underlying retraction.

Considering that all misconducts were directed by an anonymous author during initial manuscripts’ submissions without my permission or knowledge, I opened a case in Iran’s Cyber Police (FATA) to unravel the true identity of the submitting author.

Accordingly, after Cyber Police’s investigation revealed the true identity of the submitting author, I filed a complaint against the accused person (Mr. J. Javanbakht) for identity fraud in the General and Revolutionary Prosecutor’s Office (District 31 of Tehran, Iran). However, after several years of careful investigations accompanied by the opinions of the members of expert panels and Cyber Police’s report, the trial court (the Branch no.1040 of Criminal Court 2, Shahid Qodousi Judicial Complex in Tehran) convicted Mr. J. Javanbakht for the forgery of data by creating and using fake e-mail addresses attributed to reputable authors and reviewers (identity fraud) upon initial submission of manuscripts [1,2,3,4,5,6,7,8,9,10,11,12,13]. The trial court verdict was issued under no. 140,068,390,008,027,479 on 05/09/2021. Subsequently, the court of appeal (the Branch no.67 of Tehran Province Court of Appeal) decisively confirmed the trial court decision as the final verdict issued under no. 140,168,390,006,910,053, on 16/08/2022.

In this regard, along with a brief disclosure report published by Retraction Watch [14], a relevant statement has been published in the Journal of Tumor Biology where the disclosed information was duly confirmed following an investigation conducted by the Editor-in-Chief in collaboration with Iran embassy in Warsaw [15].

Data availability

Court verdicts that are officially translated and certified by the Iran Ministry of Foreign Affairs, can be shared by the Editor-in-Chief or the editorial office of Diagnostic Pathology upon reasonable request.

References

  1. Ajdarkosh H, Dadpay M, Yahaghi E, Pirzaman ER, Fayyaz AF, Darian EK, et al. Decrease expression and clinicopathological significance of miR-148a with poor survival in hepatocellular carcinoma tissues. Diagn Pathol. 2016;11105. https://0-doi-org.brum.beds.ac.uk/10.1186/s13000-016-0561-8.

  2. Abedinzadeh N, Darvish M, Gilasgar M, Nodushan SMHT, Sadeghian Y, Pedram B, et al. A histopathological analysis of the epidemiology of coronary atherosclerosis: an autopsy study. Diagn Pathol. 2016;11127. https://0-doi-org.brum.beds.ac.uk/10.1186/s13000-016-0558-3.

  3. Nasoori A, Pedram B, Kamyabi-Moghaddam Z, Mokarizadeh A, Pirasteh H, Fayyaz AF, et al. Clinicopathologic characterization of visceral gout of various internal organs-a study of 2 cases from a venom and toxin research center. Diagn Pathol. 2016;11123. https://0-doi-org.brum.beds.ac.uk/10.1186/s13000-016-0569-0.

  4. Yaghoobi Yeganeh Manesh J, Shafiee R, Mohammad Bahrami A, Pourzaer M, Pedram B, Javanbakht J, et al. Cyto-histopathological and outcome features of the prepuce squamous cell carcinoma of a mixed breed dog. Diagn Pathol. 2016;11:115. https://0-doi-org.brum.beds.ac.uk/10.1186/s13000-016-0577-0.

    Article  Google Scholar 

  5. Maghsoudi O, Mirjalili SH, Dolatabadi M, Joshaghani MF, Zarea M, Yahaghi, et al. Investigations of renal function using the level of neutrophil gelatinase-associated lipocalin associated with single-dose of cisplatin during chemotherapy. Diagn Pathol. 2016;11:114. https://0-doi-org.brum.beds.ac.uk/10.1186/s13000-016-0559-2.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Mirghasemi A, Taheriazam A, Karbasy SH, Torkaman A, Shakeri M, Yahaghi E, et al. Down-regulation of miR-133a and miR-539 are associated with unfavorable prognosis in patients suffering from osteosarcoma. Cancer Cell Int. 2016;16:84. https://0-doi-org.brum.beds.ac.uk/10.1186/s12935-016-0359-5.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Tavasoly A, Gholami H, Rostami A, Anissian A, Touni SR, Khaleghian P, et al. Clinico-histopathologic and outcome features of cutaneous infundibular keratinizing acanthoma: a case report and literature review. World J Surg Oncol. 2016;14:282. https://0-doi-org.brum.beds.ac.uk/10.1186/s12957-016-1032-0.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Sadeghian Y, Kamyabi-Moghaddam Z, Nodushan S M H T, Khoshbakht S, Pedram B, Yahaghi E, et al. Profiles of tissue microRNAs; miR-148b and miR-25 serve as potential prognostic biomarkers for hepatocellular carcinoma. Tumor Biology. 2016;37(12):16379–80. https://0-doi-org.brum.beds.ac.uk/10.1007/s13277-015-3799-y.

    Article  CAS  Google Scholar 

  9. Ebrahimi T, Pirasthe H, Rezakhaniha B, Dormanesh B, Rabati RG, Yahaghi E, et al. The value of U-NGAL expression as a potential prognostic biomarker in patients with renal cancer after neoadjuvant chemotherapy with cisplatin. Tumor Biology. 2016;37:16377. https://0-doi-org.brum.beds.ac.uk/10.1007/s13277-015-3680-z.

    Article  CAS  Google Scholar 

  10. Shafiee R, Shariat A, Khalili S, Malayeri HZ, Mokarizadeh A, Anissian A, et al. Diagnostic investigations of canine prostatitis incidence together with benign prostate hyperplasia, prostate malignancies, and biochemical recurrence in high-risk prostate cancer as a model for human study. Tumor Biology. 2016;37:16419. https://0-doi-org.brum.beds.ac.uk/10.1007/s13277-016-5475-2.

    Article  Google Scholar 

  11. Hosseini E, Pedram B, Bahrami AM, Touni SR, Malayeri HZ, Mokarizadeh A, et al. Diagnostic procedures for improving of the KIT (CD117) expressed allele burden for the liver metastases from uterus mast cell tumors: prognostic value of the metastatic pattern and tumor biology. Tumor Biology. 2016;37:16415–6. https://0-doi-org.brum.beds.ac.uk/10.1007/s13277-016-5474-3.

    Article  Google Scholar 

  12. Yaghoobi Yeganeh Manesh J, Shafiee R, Pedram B, Malayeri HZ, Mohajer S, Ahmadi S, et al. Improving the diagnosis, treatment, and biology patterns of feline mammary intraepithelial lesions: a potential model for human breast masses with evidence from epidemiologic and cytohistopathologic studies. Tumor Biology. 2016;37:16413. https://0-doi-org.brum.beds.ac.uk/10.1007/s13277-016-5472-5.

    Article  Google Scholar 

  13. Ebrahimi A, Tabatabaei Nodushan SMH, Mousavian A, Mokarizadeh A, Abbasi M, Yahaghi E, et al. Diagnostic and prognostic potentials of KLF6 and HER3 expression alterations in cutaneous malignant melanoma. Tumor Biology. 2016;37:16391. https://0-doi-org.brum.beds.ac.uk/10.1007/s13277-015-4236-y.

    Article  CAS  Google Scholar 

  14. Kincaid E. https://retractionwatch.com/2022/11/21/scientist-goes-to-court-to-clear-his-name-after-fake-peer-review-retractions/#more-126065.

  15. Mokarizadeh A. A statement regarding the mass retraction of Iranian papers in November 2016. Tumour Biol. 2023;45(1):23–24. https://0-doi-org.brum.beds.ac.uk/10.3233/TUB-220031. PMID: 37125598.

Download references

Funding

Not applicable.

Author information

Authors and Affiliations

Authors

Contributions

AM wrote the manuscript and takes full responsibility for the content.

Corresponding author

Correspondence to Aram Mokarizadeh.

Ethics declarations

Ethical approval

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mokarizadeh, A. The court’s judgment on the true identity of the author responsible for identity fraud and the consequent batch retraction of Iranian’s papers in the journal of diagnostic pathology. Diagn Pathol 19, 31 (2024). https://0-doi-org.brum.beds.ac.uk/10.1186/s13000-024-01459-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://0-doi-org.brum.beds.ac.uk/10.1186/s13000-024-01459-4

Keywords